Westwood Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Westwood Wealth Management's PFE Position: Q1 2026 in Review
Westwood Wealth Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 29,234 shares — an estimated $728K sold.
Westwood Wealth Management first reported a position in PFE in Q4 2021 and held it in 8 quarters. The position peaked at $1.11M in Q4 2021. 2,940 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Westwood Wealth Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Westwood Wealth Management sold 29,234 Pfizer shares in Q1 2026, an estimated $728K.
- Westwood Wealth Management first reported a position in Pfizer in Q4 2021 and held it in 8 quarters.
- Westwood Wealth Management's Pfizer position peaked at $1.11M in Q4 2021.
- 2,940 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Westwood Wealth Management's 13F filing for Q1 2026, filed 11 May 2026.